Floatz logo

fc-12738

Tolerance

Neurodegenerative Disease Research IncPhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Tolerance cohort.

Asset / SponsorPhaseRating
Vaxigrip
Medical University of Warsaw
Phase 4BB
Ertugliflozin
Getz Pharma
Phase 4BB
Hydrochlorothiazide
Northern California Institute of Research and Education
Phase 2B
SIMVASTATIN
Northern California Institute of Research and Education
Phase 2B
Acetylsalicylic Acid
Northern California Institute of Research and Education
Phase 2B

View all 10 →

Same molecule, other indications

fc-12738 is also rated in:

Safety IssuesDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →